Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-06
1995-08-01
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142342, 544127, 546118, A61K 31435, C07D47104
Patent
active
054380634
ABSTRACT:
Novel imidazopyridine derivatives of formula I ##STR1## wherein ##STR2## and R.sup.1, R.sup.2, R.sup.3, R.sup.4, X and Y are as defined herein, and their salts, exhibit antagonistic properties toward angiotensin II and can be used for the treatment of hypertension, aldosteronism, cardiac insufficiency and increased intraocular pressure, and of disorders of the central nervous system.
REFERENCES:
patent: 4880804 (1989-11-01), Carini et al.
patent: 5223499 (1993-06-01), Greenlee
patent: 5242928 (1993-09-01), Mederski
patent: 5243054 (1993-09-01), Naka et al.
patent: 5332744 (1994-07-01), Chakravarty
Wong, The Journal of Pharmacology and Experimental Therapeutics, vol. 252, No. 2, pp. 719-725 (1990).
Chiu, The Journal of Pharmacology and Experimental Therapeutics, vol. 250, No. 3, pp. 867-874 (1989).
Beier Norbert
Dorsch Dieter
Lues Ingeborg
Mederski Werner
Minck Klaus-Otto
Chang Ceila
Huang Evelyn
Merck Patent Gesellschaft mit beschrankter Haftung
LandOfFree
Imidazopyridines as angiotensin II antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridines as angiotensin II antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridines as angiotensin II antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-733975